ebomi
Colour theme
Sign in
Insider · CIK 0001729408

venBio Global Strategic GP II, Ltd.

CIK 0001729408 Name as filed on the most recent filing

Filed as venBio Global Strategic GP II, Ltd. (23)

50 transaction lines · from 23 filings · filed 2019-06-25 to 2022-05-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2022-05-16 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 1,001,100, disposed Open Form 4 filing 0001567619-22-011111
2022-05-13 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 374,464, disposed Open Form 4 filing 0001567619-22-011111
2022-05-12 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 1,294,313, disposed Open Form 4 filing 0001567619-22-010353
2022-05-11 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 183,641, disposed Open Form 4 filing 0001567619-22-010353
2022-05-10 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 193,870, disposed Open Form 4 filing 0001567619-22-010353
2022-05-09 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 182,582, disposed Open Form 4 filing 0001567619-22-009850
2022-05-06 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 501,233, disposed Open Form 4 filing 0001567619-22-009850
2022-05-05 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 215,105, disposed Open Form 4 filing 0001567619-22-009850
2022-05-04 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 388,924, disposed Open Form 4 filing 0001567619-22-009528
2022-05-03 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 824,434, disposed Open Form 4 filing 0001567619-22-009528
2022-05-02 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 1,595,975, disposed Open Form 4 filing 0001567619-22-009528
2022-04-29 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 718,663, disposed Open Form 4 filing 0001567619-22-009203
2022-04-28 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 761,936, disposed Open Form 4 filing 0001567619-22-009203
2022-04-27 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 491,980, disposed Open Form 4 filing 0001567619-22-009203
2022-04-26 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 671,558, disposed Open Form 4 filing 0001567619-22-008985
2022-04-25 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 287,404, disposed Open Form 4 filing 0001567619-22-008985
2022-04-22 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 388,834, disposed Open Form 4 filing 0001567619-22-008985
2022-04-21 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 645,866, disposed Open Form 4 filing 0001567619-22-008823
2022-04-20 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 889,387, disposed Open Form 4 filing 0001567619-22-008823
2022-04-19 S, Open-market sale Checkmate Pharmaceuticals, Inc.CMPI 4,165,238, disposed Open Form 4 filing 0001567619-22-008823
2021-04-27 P, Open-market purchase Impel Neuropharma IncIMPL 6,750,000, acquired Open Form 4 filing 0000905148-21-000408
2020-08-11 P, Open-market purchase Checkmate Pharmaceuticals, Inc.CMPI 3,000,000, acquired Open Form 4 filing 0000905148-20-000880
2020-07-21 P, Open-market purchase ALX Oncology Holdings IncALXO 2 lines 16,207,000, acquired Open Form 4 filing 0000905148-20-000827
2020-07-06 S, Open-market sale Akero Therapeutics, Inc.AKRO 155,721, disposed Open Form 4 filing 0000905148-20-000773
2020-07-02 S, Open-market sale Akero Therapeutics, Inc.AKRO 127,805, disposed Open Form 4 filing 0000905148-20-000773
2020-07-01 S, Open-market sale Akero Therapeutics, Inc.AKRO 3,723,010, disposed Open Form 4 filing 0000905148-20-000773
2020-03-06 S, Open-market sale Akero Therapeutics, Inc.AKRO 42,831, disposed Open Form 4 filing 0001012975-20-000291
2020-03-05 S, Open-market sale Akero Therapeutics, Inc.AKRO 200,011, disposed Open Form 4 filing 0001012975-20-000291
2020-03-04 S, Open-market sale Akero Therapeutics, Inc.AKRO 848,766, disposed Open Form 4 filing 0001012975-20-000291
2020-03-03 S, Open-market sale Akero Therapeutics, Inc.AKRO 147,199, disposed Open Form 4 filing 0001012975-20-000275
2020-03-02 S, Open-market sale Akero Therapeutics, Inc.AKRO 237,459, disposed Open Form 4 filing 0001012975-20-000275
2020-02-28 S, Open-market sale Akero Therapeutics, Inc.AKRO 108,652, disposed Open Form 4 filing 0001012975-20-000275
2020-02-27 S, Open-market sale Akero Therapeutics, Inc.AKRO 40,144, disposed Open Form 4 filing 0001012975-20-000267
2020-02-26 S, Open-market sale Akero Therapeutics, Inc.AKRO 56,615, disposed Open Form 4 filing 0001012975-20-000267
2020-02-25 S, Open-market sale Akero Therapeutics, Inc.AKRO 37,876, disposed Open Form 4 filing 0001012975-20-000267
2020-02-12 S, Open-market sale Akero Therapeutics, Inc.AKRO 163, disposed Open Form 4 filing 0001012975-20-000119
2020-02-11 S, Open-market sale Akero Therapeutics, Inc.AKRO 59,068, disposed Open Form 4 filing 0001012975-20-000119
2020-02-10 S, Open-market sale Akero Therapeutics, Inc.AKRO 212,168, disposed Open Form 4 filing 0001012975-20-000119
2020-02-06 S, Open-market sale Akero Therapeutics, Inc.AKRO 164,955, disposed Open Form 4 filing 0001012975-20-000115
2020-02-05 S, Open-market sale Akero Therapeutics, Inc.AKRO 743,548, disposed Open Form 4 filing 0001012975-20-000113
2020-02-04 S, Open-market sale Akero Therapeutics, Inc.AKRO 1,378,179, disposed Open Form 4 filing 0001012975-20-000113
2020-01-13 S, Open-market sale Akero Therapeutics, Inc.AKRO 9,993,620, disposed Open Form 4 filing 0001012975-20-000033
2020-01-08 S, Open-market sale Akero Therapeutics, Inc.AKRO 311,355, disposed Open Form 4 filing 0001012975-20-000029
2020-01-07 S, Open-market sale Akero Therapeutics, Inc.AKRO 625,149, disposed Open Form 4 filing 0001012975-20-000022
2020-01-06 S, Open-market sale Akero Therapeutics, Inc.AKRO 829,381, disposed Open Form 4 filing 0001012975-20-000022
2020-01-03 S, Open-market sale Akero Therapeutics, Inc.AKRO 241,214, disposed Open Form 4 filing 0001012975-20-000013
2020-01-02 S, Open-market sale Akero Therapeutics, Inc.AKRO 458,507, disposed Open Form 4 filing 0001012975-20-000013
2019-12-31 S, Open-market sale Akero Therapeutics, Inc.AKRO 343,259, disposed Open Form 4 filing 0001012975-20-000009
2019-06-24 P, Open-market purchase Akero Therapeutics, Inc.AKRO 4,000,000, acquired Open Form 4 filing 0001012975-19-000449

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. venBio Global Strategic GP II, Ltd., insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001729408

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.